Sana Biotechnology Inc vs Sirius XM Holdings Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Sirius XM Holdings Inc trades at $30.27 (market cap $10.30B). The key difference: Sirius XM Holdings Inc is far larger — about 11.8× Sana Biotechnology Inc's market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SIRI | |
|---|---|---|
Market Cap | $873.84M | $10.30B |
Sector | Health | Media |
52-Week High | $5.92 | $31.22 |
52-Week Low | $2.68 | $19.92 |
Enterprise Value | $848.03M | $19.97B |
Dividend Yield | — | 3.53% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →